AWM
BNTX icon

Activest Wealth Management’s BioNTech BNTX Stock Holding History

Activest Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-391
Closed -$58.7K – 344
2022
Q4 		$58.7K Hold
391
– – 0.02% 173
2022
Q3 		$53K Buy
391
+390
+39,000% +$59.6K 0.02% 174
2022
Q2 		$0 Hold
1
– – ﹤0.01% 372
2022
Q1 		$0 Sell
1
-120
-99% -$20.2K ﹤0.01% 339
2021
Q4 		$31K Buy
+121
New +$33.1K 0.02% 133

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Activest Wealth Management's BNTX Position: Q1 2023 in Review

Activest Wealth Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 391 shares — an estimated $58.7K sold.

Activest Wealth Management first reported a position in BNTX in Q4 2021 and held it in 5 quarters. The position peaked at $58.7K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Activest Wealth Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Activest Wealth Management sold 391 BioNTech shares in Q1 2023, an estimated $58.7K.
  • Activest Wealth Management first reported a position in BioNTech in Q4 2021 and held it in 5 quarters.
  • Activest Wealth Management's BioNTech position peaked at $58.7K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Activest Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.